Item 2.02 Results of Operations and Financial Condition.

On May 11, 2021, Taysha Gene Therapies, Inc. (the "Company") reported financial results for the quarter ended March 31, 2021. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference.

The information in this Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



                Exhibit
                  No.                   Description

                99.1        Press Release, dated May 11, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses